Changes for page Customer segments in Health and Wellbeing Living Labs
Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 7.1
edited by Sarantis Dimitriadis
on 2023/05/30 09:35
on 2023/05/30 09:35
Change comment:
There is no comment for this version
To version 5.5
edited by Sarantis Dimitriadis
on 2022/06/02 10:48
on 2022/06/02 10:48
Change comment:
There is no comment for this version
Summary
-
Page properties (1 modified, 0 added, 0 removed)
Details
- Page properties
-
- Content
-
... ... @@ -7,8 +7,6 @@ 7 7 (% class="western" lang="en-GB" style="text-align:justify" %) 8 8 (% lang="en-US" %)End users can be classified to non-professional and professional groups. Typical non-professional and professional end-user groups in health and wellbeing includes the following: 9 9 10 -: 11 - 12 12 * ((( 13 13 (% lang="en-US" %)**Non-professional end users:** 14 14 ... ... @@ -17,8 +17,6 @@ 17 17 * (% lang="en-US" %)**Public health and social service clients: **Those who use public services. 18 18 ))) 19 19 20 -: 21 - 22 22 * ((( 23 23 (% lang="en-US" %)**Professional end users** 24 24 ... ... @@ -29,13 +29,9 @@ 29 29 * (% lang="en-US" %)**Policy and decisions makers:** Those responsible for making policies and decisions at local, regional, national or international level. 30 30 ))) 31 31 32 -: 33 - 34 34 (% class="western" lang="en-GB" %) 35 35 (% lang="en-US" %)**Business-to-Business Customer (B2B):** B2B-customer is an organization that purchases living lab services from a living lab. B2B-customers can be classified to private, public, education/ research, civil society organizations and networks/cluster groups as follows: 36 36 37 -: 38 - 39 39 * ((( 40 40 (% lang="en-US" %)**Private sector organizations: **(business developers and researchers) 41 41 ... ... @@ -50,8 +50,6 @@ 50 50 * (% lang="en-US" %)Pharmaceutical companies 51 51 ))) 52 52 53 -: 54 - 55 55 * ((( 56 56 (% lang="en-GB" %) 57 57 (% lang="en-US" %)**Public sector organizations:** ... ... @@ -67,8 +67,6 @@ 67 67 * (% lang="en-US" %)**Public funder:** Government or other European, national, regional or local public institutions who is providing public funding for a specific living lab living lab research project via call for application process. 68 68 ))) 69 69 70 -: 71 - 72 72 * ((( 73 73 (% lang="en-GB" %) 74 74 (% lang="en-US" %)**Education and research organizations:** ... ... @@ -82,8 +82,6 @@ 82 82 * (% lang="en-US" %)**Private research organizations** such as technology and innovation centers 83 83 ))) 84 84 85 -: 86 - 87 87 * ((( 88 88 (% lang="en-GB" %) 89 89 (% lang="en-US" %)**Civil society organizations:** ... ... @@ -91,8 +91,6 @@ 91 91 * (% lang="en-US" %)Non-governmental organizations (NGO) and nonprofit entities operating at international, national, regional or local level. 92 92 ))) 93 93 94 -: 95 - 96 96 * ((( 97 97 (% lang="en-GB" %) 98 98 (% lang="en-US" %)**Networks and clusters:** ... ... @@ -101,89 +101,240 @@ 101 101 * (% lang="en-US" %)International, national, regional and local networks 102 102 ))) 103 103 104 -: 105 - 106 106 (% class="western" lang="en-GB" %) 107 -(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in thefollowing table .89 +(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in Table . 108 108 109 -(% style="height:1004px; margin-left:auto; margin-right:auto; width:1694px" %) 110 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)**Age groups** 111 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 91 +(% cellspacing="0" style="border-collapse:collapse; margin-left:auto; margin-right:auto" %) 92 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)((( 93 +(% class="western" lang="en-GB" style="text-align:center" %) 94 +(% lang="en-US" %)**Age or age group** 95 +))) 96 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:11px; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 97 +(% class="western" lang="en-GB" %) 112 112 (% lang="en-US" %)Specific age range 113 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 99 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 100 +(% class="western" %) 114 114 115 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((102 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 116 116 (% class="western" %) 117 117 118 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)(((105 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:152px" %)((( 119 119 (% class="western" %) 120 120 121 121 ))) 122 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Adolescents|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)Older Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)General Population 123 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)((( 109 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 110 +(% class="western" lang="en-GB" %) 111 +(% lang="en-US" %)Elderly 112 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 113 +(% class="western" lang="en-GB" %) 114 +(% lang="en-US" %)Adults 115 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 116 +(% class="western" lang="en-GB" %) 117 +(% lang="en-US" %)Youth 118 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:152px" %)((( 119 +(% class="western" lang="en-GB" %) 120 +(% lang="en-US" %)Children 121 +))) 122 +|(% colspan="4" style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:12px; padding:0in; vertical-align:top; width:634px" %)((( 124 124 (% class="western" %) 125 125 126 126 ))) 127 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adolescents Health status (disease, disorder or disability)** 128 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 126 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:12px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)((( 127 +(% class="western" lang="en-GB" style="text-align:center" %) 128 +(% lang="en-US" %)**Health status** 129 +))) 130 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 129 129 (% class="western" lang="en-GB" %) 130 130 (% lang="en-US" %)Healthy 131 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 133 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 132 132 (% class="western" lang="en-GB" %) 133 - 134 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 135 +(% lang="en-US" %)Patient 136 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 135 135 (% class="western" lang="en-GB" %) 136 - 137 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)((( 138 +(% lang="en-US" %)Rehabilitant 139 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:152px" %)((( 138 138 (% class="western" lang="en-GB" %) 139 - 141 +(% lang="en-US" %)Recovered/Survivor 140 140 ))) 141 -|(% colspan="4" style="border- color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((143 +|(% colspan="4" style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:12px; padding:0in; vertical-align:top; width:634px" %)((( 142 142 (% class="western" %) 143 143 144 144 ))) 145 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adults Health status (disease, disorder or disability)** 146 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Healthy|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Schizophrenia|Multiple-Sclerosis|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Parkinson Disease 147 -|(% style="height:30px; width:153px" %)Post-Stroke Patients with Moving or Linguistic Disability|Mild Cognitive Impairment|Sleep Disorders: e.g., Apnea, Hypopnea|With Disability 148 -|Healthy with Possible Chronic Conditions|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %) 149 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)((( 147 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:12px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)((( 148 +(% class="western" lang="en-GB" style="text-align:center" %) 149 +(% lang="en-US" %)**A specific disease, disorder or disability** 150 +))) 151 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 152 +(% class="western" lang="en-GB" %) 153 +(% lang="en-US" %)ADHD 154 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 155 +(% class="western" lang="en-GB" %) 156 +(% lang="en-US" %)Dementia 157 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 158 +(% class="western" lang="en-GB" %) 159 +(% lang="en-US" %)Parkinsons’ disease 160 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 161 +(% class="western" lang="en-GB" %) 162 +(% lang="en-US" %)Loneliness and Social Isolation 163 +))) 164 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:11px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 165 +(% class="western" lang="en-GB" %) 166 +(% lang="en-US" %)Autism 167 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 168 +(% class="western" lang="en-GB" %) 169 +(% lang="en-US" %)Down syndrome 170 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 171 +(% class="western" lang="en-GB" %) 172 +(% lang="en-US" %)Physical disability 173 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 174 +(% class="western" lang="en-GB" %) 175 +(% lang="en-US" %)Mental health 176 +))) 177 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 178 +(% class="western" lang="en-GB" %) 179 +(% lang="en-US" %)Cardiovascular disease 180 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 181 +(% class="western" lang="en-GB" %) 182 +(% lang="en-US" %)Idiopathic pulmonary fibrosis (IPF) 183 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 184 +(% class="western" lang="en-GB" %) 185 +(% lang="en-US" %)Sleep apnea/apnea 186 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 187 +(% class="western" lang="en-GB" %) 188 +(% lang="en-US" %)Mild cognitive impairment 189 +))) 190 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 191 +(% class="western" lang="en-GB" %) 192 +(% lang="en-US" %)Chronic Obstructive Pulmonary Disease (COPD) 193 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 194 +(% class="western" lang="en-GB" %) 195 +(% lang="en-US" %)Language disability 196 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 197 +(% class="western" lang="en-GB" %) 198 +(% lang="en-US" %)Substance abuse (drugs, alcohol) 199 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 200 +(% class="western" lang="en-GB" %) 201 +(% lang="en-US" %)Multiple sclerosis 202 +))) 203 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 204 +(% class="western" lang="en-GB" %) 205 +(% lang="en-US" %)Cognitive disorder (mild, major) 206 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 207 +(% class="western" lang="en-GB" %) 208 +(% lang="en-US" %)Intellectual disability/ Learning difficulty/ Mental retardation 209 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 210 +(% class="western" lang="en-GB" %) 211 +(% lang="en-US" %)Trauma patient 212 + 213 +(% class="western" lang="en-GB" %) 214 +(% lang="en-US" %)(e.g., a spinal cord injury) 215 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 216 +(% class="western" lang="en-GB" %) 217 +(% lang="en-US" %)Neurodegenerative diseases 218 +))) 219 +|(% colspan="4" style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:12px; padding:0in; vertical-align:top; width:634px" %)((( 150 150 (% class="western" %) 151 151 152 152 ))) 153 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Older Adults Health status (disease, disorder or disability)** 154 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Healthy|Parkinson Disease|Mild Cognitive Impairment|With Disability|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 223 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:12px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)((( 224 +(% class="western" lang="en-GB" style="text-align:center" %) 225 +(% lang="en-US" %)**Clients of a specific service** 226 +))) 227 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:11px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 228 +(% class="western" lang="en-GB" %) 229 +(% lang="en-US" %)Child welfare 230 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 231 +(% class="western" lang="en-GB" %) 232 +(% lang="en-US" %)Nursing home 233 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 234 +(% class="western" lang="en-GB" %) 235 +(% lang="en-US" %)Employment service 236 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 155 155 (% class="western" %) 156 156 157 157 ))) 158 -|(% style=" height:30px; width:153px" %)Healthy with Possible Chronic Conditions|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((240 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 159 159 (% class="western" lang="en-GB" %) 160 - 161 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 242 +(% lang="en-US" %)Early childhood education 243 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 162 162 (% class="western" lang="en-GB" %) 245 +(% lang="en-US" %)Home care 246 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 247 +(% class="western" lang="en-GB" %) 163 163 164 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 249 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 165 165 (% class="western" lang="en-GB" %) 166 166 167 167 ))) 168 -|(% colspan="4" style="border- color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((253 +|(% colspan="4" style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:12px; padding:0in; vertical-align:top; width:634px" %)((( 169 169 (% class="western" %) 170 170 171 171 ))) 172 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**General Population Health status (disease, disorder or disability)** 173 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Healthy|Ipf Patients|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Prostate Cancer|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 257 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:12px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)((( 258 +(% class="western" lang="en-GB" style="text-align:center" %) 259 +(% lang="en-US" %)**Vulnerable groups** 260 +))) 261 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 174 174 (% class="western" lang="en-GB" %) 175 -Down Syndrome 263 +(% lang="en-US" %)Minors/Children 264 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 265 +(% class="western" lang="en-GB" %) 266 +(% lang="en-US" %)Single parents with minor children 267 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 268 +(% class="western" lang="en-GB" %) 269 +(% lang="en-US" %)Persons subjected to psychological, physical or sexual violence 270 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 271 +(% class="western" lang="en-GB" %) 272 +(% lang="en-US" %)Substance users 273 + 274 +(% class="western" lang="en-GB" %) 275 +(% lang="en-US" %)(drugs, alcohol) 176 176 ))) 177 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Chronical Diseases: e.g., Persons With Chronic Pulmonary (Copd)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Cardiological Or Other Conditions (Aphasia)|(% style="border-color:currentcolor;border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Breast Cancer Survivors|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((277 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 178 178 (% class="western" lang="en-GB" %) 279 +(% lang="en-US" %)Disabled people 280 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 281 +(% class="western" lang="en-GB" %) 282 +(% lang="en-US" %)Victims of trafficking in human beings 283 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 284 +(% class="western" lang="en-GB" %) 285 +(% lang="en-US" %)Ethnic minorities and immigrants 286 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 287 +(% class="western" lang="en-GB" %) 288 +(% lang="en-US" %)Isolated people 289 +))) 290 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 291 +(% class="western" lang="en-GB" %) 292 +(% lang="en-US" %)Elderly people 293 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 294 +(% class="western" lang="en-GB" %) 295 +(% lang="en-US" %)Persons with serious illnesses 296 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 297 +(% class="western" lang="en-GB" %) 298 +(% lang="en-US" %)Homeless people 299 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 300 +(% class="western" lang="en-GB" %) 301 +(% lang="en-US" %)Ex-prisoners and people with criminal background 302 +))) 303 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 304 +(% class="western" lang="en-GB" %) 305 +(% lang="en-US" %)Pregnant women 306 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 307 +(% class="western" lang="en-GB" %) 308 +(% lang="en-US" %)Persons with mental disorders 309 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 310 +(% class="western" lang="en-GB" %) 179 179 312 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 313 +(% class="western" lang="en-GB" %) 314 + 180 180 ))) 181 181 182 -: 183 183 184 184 (% class="western" lang="en-GB" %) 185 -(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the tablebelow(% style="page-break-before:always" %).319 +(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in Table . 186 186 321 + 187 187 |**Researcher expertise**|**Brief use case description** 188 188 |Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making 189 189 |Experts in communication studies|Defining written, oral, visual and digital communication within a certain workplace. Evaluating (multi professional) healthcare team collaboration, communication and debriefing in various healthcare situations in simulated environments (especially in Simulation lab)